BioSpace News Archive

InMed’s Eric Hsu and Michael Woudenberg among Event’s Expert Speakers

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (“MD Anderson”), today announced that it is planning a proof of concept (POC) clinical trial for the use of its RAP technology for the treatment of keloid and hypertrophic scars.

Can-Fite BioPharma Ltd. announced financial results for the six months ended June 30, 2019.

Heska Corporation (NASDAQ: HSKA - News; “Heska” or the “Company”), a provider of advanced veterinary diagnostic and specialty healthcare products, today announced the realignment of its executive officers and the promotion in connection therewith of Nancy Wisnewski,

Inc. magazine today revealed that Legwork is No. 1169 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies.

Geyser Brands Inc. (TSXV:GYSR) (“Geyser Brands” or the “Company”) today released its Q1 financial statements for the three months ended June 30, 2019.

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Delivery Technology, today announced that members of its management team will participate in the following upcoming conferences in September:

Ocular Therapeutix, Inc. (NASDAQ:OCUL) today announced that Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix, will give a company presentation on Thursday, September 5th at 2:30 p.m. EDT at the 2019 Wells Fargo Healthcare Conference at the Westin Copley Place Hotel in Boston, MA.

Paradigm, the industry leader in solving catastrophic and complex health care challenges and improving lives, announced today the appointment of Kathy Galia as Chief Operating Officer (COO) of the Catastrophic Care Management division, effective September 9.

VERDEMED HOLDINGS INC. is pleased to announce the appointment of Mr. David Beatty as a member of its Board of Directors, and Mr. Alexandre Penha as Chief Financial Officer.